The present invention provides a pharmaceutical product for treatment and/or prevention of cancer, characterized by including imiquimod together or separately in combination with an antibody, or a fragment thereof, having immunological reactivity with a CAPRIN-1 protein. With this pharmaceutical product, it is possible to treat and/or prevent cancer that specifically expresses the CAPRIN-1 protein on a cell surface.
